Co-design of a Seamless Person-centered Intervention to Optimize Medication Use Across Healthcare Levels

Launched by MALIN OLSEN SYVERSEN · Jun 13, 2022

Keywords

ClinConnect Summary

This clinical trial is focused on improving how medications are managed for patients with multiple long-term health conditions. These patients often have complex medication needs, and mistakes can happen when they move between different levels of healthcare, like when they leave the hospital. The researchers want to understand the common medication errors that occur after hospital discharge and find ways to make the transition smoother. They will gather insights from patients, their family members, and healthcare professionals to create a better system that ensures everyone is on the same page about medication use.

To participate in this study, you must be an adult living in Oslo who is scheduled to leave the hospital and manage your medications at home. You should be taking at least four regular medications from different classes and be able to provide informed consent. If you join the study, you can expect to share your experiences with medication management and help improve care for others. This research aims to enhance communication and support around medication use, ultimately leading to better health outcomes and quality of life for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Patients:
• • Adult ≥ 18 years
• • Gives written, informed consent to participate in the study. If the patient is not competent to consent, consent can be obtained from the patient's next of kin.
• • Residential address in Oslo
• • Lives at home and normally manage their medications themselves (might have help from home-care nurses or next of kin)
• • Scheduled to be discharged from the wards to their home or to short-term stay in nursing homes
• • Uses at least four regular medications from at least two therapy classes (Anatomical Therapeutic Chemical (ATC) at first level
• Health care personnel (HCP) and next of kin:
• • Expected to be involved in the included patient's medication regime or management after hospital discharge
• • Able and willing to give written, informed consent to participate in the study
• • HCP should be general practitioners (GPs) or home-care nurses.
• Exclusion Criteria:
• Patients:
• • Terminal and/or isolated due to infections
• • Has previously been included in the study
• • Has advanced cognitive failure, in accordance with assessment from treating physician
• • Will not be discharged from the included wards to their homes (for example planned transfer to another ward or long-term stay at nursing home)
• • Unable to communicate in Norwegian or English
• HCP and next of kin:
• • Unable to communicate in Norwegian or English
• • HCP or next of kin that has previously been included in the study